Sei Foundation Eyes 23andMe Acquisition to Put Genomic Data on Blockchain

The Sei Foundation, the nonprofit behind the Sei (SEI) layer-1 blockchain, is considering acquiring bankrupt personal genomics giant 23andMe. The goal? To bring the genetic data of 15 million users onto blockchain rails, ensuring privacy, ownership, and control in what it’s calling its “boldest DeSci bet yet.”

This move aligns with the foundation’s growing investment in decentralized science (DeSci). Earlier this year, Sei launched a $65 million venture fund aimed at supporting DeSci startups building on its network. Now, it’s looking to take a major leap by integrating personal genomic data into blockchain infrastructure.

23andMe, famous for its direct-to-consumer DNA testing kits, recently filed for Chapter 11 bankruptcy protection. As concerns rise over the security of sensitive genetic data, the Sei Foundation argues that data ownership and protection are matters of national security. If the acquisition goes through, users would have the ability to encrypt, store, and monetize their genetic information on the Sei blockchain, retaining full control.

“This isn’t just about saving a company,” the foundation said in a post on X. “It’s about building a future where your most personal data remains yours to control.”

The news comes amid warnings from state attorneys general urging 23andMe users to delete their data following the bankruptcy filing. The SEI token briefly rose 3% after the announcement, reflecting market interest in the potential of blockchain in biotech.

By merging genomics with blockchain, Sei aims to transform how genetic data is stored and shared—shifting power from corporations to individuals, and paving the way for a more secure, decentralized future in personal healthcare data.